SCIASCIA THOMAS bought TRVI
February 19, 2026 · Form 4 insider transaction
SCIASCIA THOMAS bought 85,000 shares of Trevi Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
85,000
Price
$0.00
Total value
N/A
InsiderSCIASCIA THOMAS
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 19, 2026
Filing dateFebruary 20, 2026
Shares owned after85,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on February 19, 2026. The 85,000 shares of common stock underlying the option are scheduled to vest in equal monthly installments through February 19, 2030, subject to the reporting person's continued service with the issuer.